GLOBAL BLOOD THERAPEUTICS IN's ticker is and the CUSIP is 37890U908. A total of 6 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,175,000 | -20.1% | 170,000 | -39.2% | 0.00% | -33.3% |
| Q4 2018 | $11,478,000 | +101.5% | 279,600 | +86.5% | 0.00% | +200.0% |
| Q3 2018 | $5,696,000 | +526.6% | 149,900 | +645.8% | 0.00% | – |
| Q2 2018 | $909,000 | -56.0% | 20,100 | -71.3% | 0.00% | – |
| Q3 2017 | $2,065,000 | – | 70,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,312 | $4,986,000 | 0.64% |
| BOOTHBAY FUND MANAGEMENT, LLC | 228 | $866,000 | 0.09% |
| GROUP ONE TRADING, L.P. | 124,400 | $4,727,000 | 0.04% |
| SIMPLEX TRADING, LLC | 421 | $1,599,000 | 0.01% |
| JPMORGAN CHASE & CO | 149,900 | $5,696,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |